ALI TABASSIAN, M.D., PH.D.
Ophthalmology Physician · RICHMOND, VA
Individual Active NPI 1679535538
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,138 | 22,685 | $4,706,595 | $2,968,606 | $2,320,178 |
| 2023 | 1,145 | 10,796 | $3,825,236 | $2,440,131 | $1,904,899 |
| 2022 | 1,207 | 8,445 | $3,922,492 | $2,592,903 | $2,024,296 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 11,280 | $34 | $27 |
| 92134 | Imaging of retina | 1,853 | $41 | $30 |
| J0178 | Injection, aflibercept, 1 mg | 1,694 | $829 | $658 |
| J2782 | Injection, avacincaptad pegol, 0.1 mg | 1,500 | $108 | $86 |
| 67028 | Injection of drug into eye | 1,347 | $126 | $93 |
| 92014 | Established patient complete exam of visual system | 1,077 | $128 | $87 |
| 92250 | Photography of the retina | 678 | $38 | $26 |
| J0177 | Injection, aflibercept hd, 1 mg | 664 | $332 | $264 |
| J2778 | Injection, ranibizumab, 0.1 mg | 245 | $160 | $126 |
| J9035 | Injection, bevacizumab, 10 mg | 173 | $72 | $54 |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 150 | $171 | $121 |
| 92004 | New patient complete exam of visual system | 82 | $152 | $97 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | 0101054624 | VA |
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | 0101054624 | VA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Virginia
- NPI 1801997176
- NPI 1154439776
- NPI 1407071202
- NPI 1811981541
- NPI 1760494835
- NPI 1619086634
- NPI 1114024189
- NPI 1821195801
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.